212 related articles for article (PubMed ID: 19911257)
1. Cross-interaction chromatography: a rapid method to identify highly soluble monoclonal antibody candidates.
Jacobs SA; Wu SJ; Feng Y; Bethea D; O'Neil KT
Pharm Res; 2010 Jan; 27(1):65-71. PubMed ID: 19911257
[TBL] [Abstract][Full Text] [Related]
2. A novel screening method to assess developability of antibody-like molecules.
Kohli N; Jain N; Geddie ML; Razlog M; Xu L; Lugovskoy AA
MAbs; 2015; 7(4):752-8. PubMed ID: 25961854
[TBL] [Abstract][Full Text] [Related]
3. An alternative assay to hydrophobic interaction chromatography for high-throughput characterization of monoclonal antibodies.
Estep P; Caffry I; Yu Y; Sun T; Cao Y; Lynaugh H; Jain T; Vásquez M; Tessier PM; Xu Y
MAbs; 2015; 7(3):553-61. PubMed ID: 25790175
[TBL] [Abstract][Full Text] [Related]
4. Measurements of Monoclonal Antibody Self-Association Are Correlated with Complex Biophysical Properties.
Geng SB; Wittekind M; Vigil A; Tessier PM
Mol Pharm; 2016 May; 13(5):1636-45. PubMed ID: 27045771
[TBL] [Abstract][Full Text] [Related]
5. Facile quantitation of free thiols in a recombinant monoclonal antibody by reversed-phase high performance liquid chromatography with hydrophobicity-tailored thiol derivatization.
Welch L; Dong X; Hewitt D; Irwin M; McCarty L; Tsai C; Baginski T
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Aug; 1092():158-167. PubMed ID: 29906677
[TBL] [Abstract][Full Text] [Related]
6. [Advances in the study of affinity selection-ultrafiltration/HPLC-MS].
Zhao HY; Zhang YZ; Xiao CL
Yao Xue Xue Bao; 2009 Oct; 44(10):1084-8. PubMed ID: 20055128
[TBL] [Abstract][Full Text] [Related]
7. A Micro-Polyethylene Glycol Precipitation Assay as a Relative Solubility Screening Tool for Monoclonal Antibody Design and Formulation Development.
Toprani VM; Joshi SB; Kueltzo LA; Schwartz RM; Middaugh CR; Volkin DB
J Pharm Sci; 2016 Aug; 105(8):2319-27. PubMed ID: 27368120
[TBL] [Abstract][Full Text] [Related]
8. Rapid and accurate in silico solubility screening of a monoclonal antibody library.
Sormanni P; Amery L; Ekizoglou S; Vendruscolo M; Popovic B
Sci Rep; 2017 Aug; 7(1):8200. PubMed ID: 28811609
[TBL] [Abstract][Full Text] [Related]
9. Solubility evaluation of murine hybridoma antibodies.
Spencer S; Bethea D; Raju TS; Giles-Komar J; Feng Y
MAbs; 2012; 4(3):319-25. PubMed ID: 22531448
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in silico assessment of the developability of a designed monoclonal antibody library.
Wolf Pérez AM; Sormanni P; Andersen JS; Sakhnini LI; Rodriguez-Leon I; Bjelke JR; Gajhede AJ; De Maria L; Otzen DE; Vendruscolo M; Lorenzen N
MAbs; 2019; 11(2):388-400. PubMed ID: 30523762
[TBL] [Abstract][Full Text] [Related]
11. The bioanalysis of the monoclonal antibody trastuzumab by high-performance liquid chromatography with fluorescence detection after immuno-affinity purification from human serum.
Damen CW; Derissen EJ; Schellens JH; Rosing H; Beijnen JH
J Pharm Biomed Anal; 2009 Dec; 50(5):861-6. PubMed ID: 19487098
[TBL] [Abstract][Full Text] [Related]
12. Biophysical and Sequence-Based Methods for Identifying Monovalent and Bivalent Antibodies with High Colloidal Stability.
Alam ME; Geng SB; Bender C; Ludwig SD; Linden L; Hoet R; Tessier PM
Mol Pharm; 2018 Jan; 15(1):150-163. PubMed ID: 29154550
[TBL] [Abstract][Full Text] [Related]
13. Discovery of highly soluble antibodies prior to purification using affinity-capture self-interaction nanoparticle spectroscopy.
Wu J; Schultz JS; Weldon CL; Sule SV; Chai Q; Geng SB; Dickinson CD; Tessier PM
Protein Eng Des Sel; 2015 Oct; 28(10):403-14. PubMed ID: 26363633
[TBL] [Abstract][Full Text] [Related]
14. Early developability screen of therapeutic antibody candidates using Taylor dispersion analysis and UV area imaging detection.
Lavoisier A; Schlaeppi JM
MAbs; 2015; 7(1):77-83. PubMed ID: 25514497
[TBL] [Abstract][Full Text] [Related]
15. A Small-Scale Process for Predicting Donnan and Volume Exclusion Effects During Ultrafiltration/Diafiltration Process Development.
Abel J; Kosky A; Ball N; Bacon H; Kaushik R; Kleemann GR
J Pharm Sci; 2018 May; 107(5):1296-1303. PubMed ID: 29339134
[TBL] [Abstract][Full Text] [Related]
16. Homology modeling and structure-based design improve hydrophobic interaction chromatography behavior of integrin binding antibodies.
Jetha A; Thorsteinson N; Jmeian Y; Jeganathan A; Giblin P; Fransson J
MAbs; 2018; 10(6):890-900. PubMed ID: 30110240
[TBL] [Abstract][Full Text] [Related]
17. Cross-Interaction Chromatography-Based QSAR Model for Early-Stage Screening to Facilitate Enhanced Developability of Monoclonal Antibody Therapeutics.
Kizhedath A; Karlberg M; Glassey J
Biotechnol J; 2019 Aug; 14(8):e1800696. PubMed ID: 30810283
[TBL] [Abstract][Full Text] [Related]
18. Ultrafiltration behavior of monoclonal antibodies and Fc-fusion proteins: Effects of physical properties.
Baek Y; Singh N; Arunkumar A; Borys M; Li ZJ; Zydney AL
Biotechnol Bioeng; 2017 Sep; 114(9):2057-2065. PubMed ID: 28464237
[TBL] [Abstract][Full Text] [Related]
19. High resolution reversed phase analysis of recombinant monoclonal antibodies by ultra-high pressure liquid chromatography column coupling.
Fekete S; Dong MW; Zhang T; Guillarme D
J Pharm Biomed Anal; 2013 Sep; 83():273-8. PubMed ID: 23770782
[TBL] [Abstract][Full Text] [Related]
20. Application of a PEG precipitation method for solubility screening: a tool for developing high protein concentration formulations.
Li L; Kantor A; Warne N
Protein Sci; 2013 Aug; 22(8):1118-23. PubMed ID: 23740802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
